(Q44905868)

7 December 2017

title

Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer's disease (English)

1 reference

7 December 2017

0 references

1 reference

Kenichi Meguro

1

1 reference

7 December 2017

Mitsue Meguro

2

1 reference

7 December 2017

Yasuhiro Tanaka

3

1 reference

7 December 2017

Kyoko Akanuma

4

1 reference

7 December 2017

Keiichiro Yamaguchi

5

1 reference

7 December 2017

Masatoshi Itoh

6

1 reference

7 December 2017

publication date

1 June 2004

1 reference

Journal of Geriatric Psychiatry and Neurology

7 December 2017

published in

1 reference

7 December 2017

volume

17

1 reference

7 December 2017

issue

2

1 reference

7 December 2017

page(s)

61-67

1 reference

Disturbance in daily sleep/wake patterns in patients with cognitive impairment and decreased daily activity

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

The `subcortical dementia' of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: A double-tracer PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Reducing the burden of caring for Alzheimer's disease through the amelioration of "delusions of theft" by drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

The effects of group work therapy in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Therapeutic psychosocial intervention for elderly subjects with very mild Alzheimer disease in a community: the tajiri project

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Distribution volume ratios without blood sampling from graphical analysis of PET data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Loss of social group affinity following prefrontal lesions in free-ranging macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Serotonin-dopamine interaction and its relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0891988704264535

21 January 2018

Identifiers

DOI

10.1177/0891988704264535

1 reference

release_f4tjkh5gp5bsda4ps57qrfbm6u

7 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f4tjkh5gp5bsda4ps57qrfbm6u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference